Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

April 9, 2026 updated by: Chelsea Tagawa, Tripler Army Medical Center
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Rhabdomyolysis
  • chooses battlefield acupuncture

Exclusion Criteria:

  • Greater than 72 hours from onset of symptoms
  • younger than 18 years of age
  • declines battlefield acupuncture
  • no pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Battlefield Acupuncture
Patients admitted with rhabdomyolysis who choose to get battlefield acupuncture for pain control.
Procedure: Battlefield Acupuncture
Treatment of pain from rhabdomyolysis with battlefield acupuncture
No Intervention: Patients admitted with rhabdomyolysis who did not receive battlefield acupuncture
This arm is the retrospective group that did not receive the BFA as an intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Level on a pain scale of 0-10
Time Frame: Pain level will be measured through study completion (up to 12 months).
Reported pain levels on a subjective pain score of 0-10
Pain level will be measured through study completion (up to 12 months).
Pain Medication
Time Frame: From enrollment to the end of treatment at 12 months
Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7
From enrollment to the end of treatment at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Hospital Stay in days
Time Frame: Length of time from admission to discharge in days (up to 7 days)
How long the patient stays in the hospital in days
Length of time from admission to discharge in days (up to 7 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tripler Army Medical Center

Investigators

  • Principal Investigator: Chelsea W Tagawa, MD, Tripler Army Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2023

Primary Completion (Estimated)

April 24, 2028

Study Completion (Estimated)

April 24, 2028

Study Registration Dates

First Submitted

May 15, 2025

First Submitted That Met QC Criteria

April 9, 2026

First Posted (Actual)

April 14, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TAMC 23H29 / 223057

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rhabdomyolysis

Clinical Trials on Battlefield Acupuncture

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe